224 related articles for article (PubMed ID: 36835198)
21. Interaction of ligand-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasis.
Mochizuki H; Matsubara A; Teishima J; Mutaguchi K; Yasumoto H; Dahiya R; Usui T; Kamiya K
Biochem Biophys Res Commun; 2004 Jul; 320(3):656-63. PubMed ID: 15240098
[TBL] [Abstract][Full Text] [Related]
22. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
Yu X; Huang Y; Collin-Osdoby P; Osdoby P
J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
[TBL] [Abstract][Full Text] [Related]
23. Role of tyrosine phosphorylation in ligand-independent sequestration of CXCR4 in human primary monocytes-macrophages.
Wang J; Guan E; Roderiquez G; Calvert V; Alvarez R; Norcross MA
J Biol Chem; 2001 Dec; 276(52):49236-43. PubMed ID: 11668182
[TBL] [Abstract][Full Text] [Related]
24. Scavenging of CXCL12 by CXCR7 promotes tumor growth and metastasis of CXCR4-positive breast cancer cells.
Luker KE; Lewin SA; Mihalko LA; Schmidt BT; Winkler JS; Coggins NL; Thomas DG; Luker GD
Oncogene; 2012 Nov; 31(45):4750-8. PubMed ID: 22266857
[TBL] [Abstract][Full Text] [Related]
25. Upregulation of CXC chemokine receptor 4-CXC chemokine ligand 12 axis ininvasive breast carcinoma: A potent biomarker predicting lymph node metastasis.
Dayer R; Babashah S; Jamshidi S; Sadeghizadeh M
J Cancer Res Ther; 2018; 14(2):345-350. PubMed ID: 29516917
[TBL] [Abstract][Full Text] [Related]
26. Prostate cancer cells preferentially home to osteoblast-rich areas in the early stages of bone metastasis: evidence from in vivo models.
Wang N; Docherty FE; Brown HK; Reeves KJ; Fowles AC; Ottewell PD; Dear TN; Holen I; Croucher PI; Eaton CL
J Bone Miner Res; 2014 Dec; 29(12):2688-96. PubMed ID: 24956445
[TBL] [Abstract][Full Text] [Related]
27. Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response.
Koizumi K; Hojo S; Akashi T; Yasumoto K; Saiki I
Cancer Sci; 2007 Nov; 98(11):1652-8. PubMed ID: 17894551
[TBL] [Abstract][Full Text] [Related]
28. CCL27-CCR10 and CXCL12-CXCR4 chemokine ligand-receptor mRNA expression ratio: new predictive factors of tumor progression in cutaneous malignant melanoma.
Monteagudo C; Ramos D; Pellín-Carcelén A; Gil R; Callaghan RC; Martín JM; Alonso V; Murgui A; Navarro L; Calabuig S; López-Guerrero JA; Jordá E; Pellín A
Clin Exp Metastasis; 2012 Aug; 29(6):625-37. PubMed ID: 22526457
[TBL] [Abstract][Full Text] [Related]
29. The role of the CXCL12-CXCR4/CXCR7 axis in the progression and metastasis of bone sarcomas (Review).
Liao YX; Zhou CH; Zeng H; Zuo DQ; Wang ZY; Yin F; Hua YQ; Cai ZD
Int J Mol Med; 2013 Dec; 32(6):1239-46. PubMed ID: 24127013
[TBL] [Abstract][Full Text] [Related]
30. Expression of the chemokines CXCL12 and CX3CL1 and their receptors in human nerve sheath tumors.
Hattermann K; Li G; Hugo HH; Mentlein R; Mehdorn HM; Held-Feindt J
Histol Histopathol; 2013 Oct; 28(10):1337-49. PubMed ID: 23645563
[TBL] [Abstract][Full Text] [Related]
31. Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis.
Darash-Yahana M; Pikarsky E; Abramovitch R; Zeira E; Pal B; Karplus R; Beider K; Avniel S; Kasem S; Galun E; Peled A
FASEB J; 2004 Aug; 18(11):1240-2. PubMed ID: 15180966
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological targeting of CXCL12/CXCR4 signaling in prostate cancer bone metastasis.
Conley-LaComb MK; Semaan L; Singareddy R; Li Y; Heath EI; Kim S; Cher ML; Chinni SR
Mol Cancer; 2016 Nov; 15(1):68. PubMed ID: 27809841
[TBL] [Abstract][Full Text] [Related]
33. CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression.
Sun X; Cheng G; Hao M; Zheng J; Zhou X; Zhang J; Taichman RS; Pienta KJ; Wang J
Cancer Metastasis Rev; 2010 Dec; 29(4):709-22. PubMed ID: 20839032
[TBL] [Abstract][Full Text] [Related]
34. Spatial and temporally restricted expression of chemokines and chemokine receptors in the developing human kidney.
Gröne HJ; Cohen CD; Gröne E; Schmidt C; Kretzler M; Schlöndorff D; Nelson PJ
J Am Soc Nephrol; 2002 Apr; 13(4):957-967. PubMed ID: 11912255
[TBL] [Abstract][Full Text] [Related]
35. CX3CL1: a potential chemokine widely involved in the process spinal metastases.
Liu W; Bian C; Liang Y; Jiang L; Qian C; Dong J
Oncotarget; 2017 Feb; 8(9):15213-15219. PubMed ID: 28122354
[TBL] [Abstract][Full Text] [Related]
36. The chemokine X-factor: Structure-function analysis of the CXC motif at CXCR4 and ACKR3.
Wedemeyer MJ; Mahn SA; Getschman AE; Crawford KS; Peterson FC; Marchese A; McCorvy JD; Volkman BF
J Biol Chem; 2020 Oct; 295(40):13927-13939. PubMed ID: 32788219
[TBL] [Abstract][Full Text] [Related]
37. CXCL12/CXCR4 transactivates HER2 in lipid rafts of prostate cancer cells and promotes growth of metastatic deposits in bone.
Chinni SR; Yamamoto H; Dong Z; Sabbota A; Bonfil RD; Cher ML
Mol Cancer Res; 2008 Mar; 6(3):446-57. PubMed ID: 18337451
[TBL] [Abstract][Full Text] [Related]
38. Chemokine and chemokine receptor expression in kidney tumors: molecular profiling of histological subtypes and association with metastasis.
Gahan JC; Gosalbez M; Yates T; Young EE; Escudero DO; Chi A; Garcia-Roig M; Satyanarayana R; Soloway MS; Bird VG; Lokeshwar VB
J Urol; 2012 Mar; 187(3):827-33. PubMed ID: 22245330
[TBL] [Abstract][Full Text] [Related]
39. Human Cytomegalovirus UL111A and US27 Gene Products Enhance the CXCL12/CXCR4 Signaling Axis via Distinct Mechanisms.
Tu CC; Arnolds KL; O'Connor CM; Spencer JV
J Virol; 2018 Mar; 92(5):. PubMed ID: 29237840
[TBL] [Abstract][Full Text] [Related]
40. Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis.
Jung Y; Kim JK; Shiozawa Y; Wang J; Mishra A; Joseph J; Berry JE; McGee S; Lee E; Sun H; Wang J; Jin T; Zhang H; Dai J; Krebsbach PH; Keller ET; Pienta KJ; Taichman RS
Nat Commun; 2013; 4():1795. PubMed ID: 23653207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]